Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021

SELL
$5.61 - $12.01 $561 - $1,201
-100 Closed
0 $0
Q4 2020

Jan 21, 2021

SELL
$6.99 - $9.26 $34,950 - $46,300
-5,000 Reduced 98.04%
100 $0
Q3 2020

Oct 27, 2020

BUY
$8.49 - $19.54 $11,037 - $25,402
1,300 Added 34.21%
5,100 $43,000
Q1 2020

May 07, 2020

SELL
$6.94 - $14.22 $79,116 - $162,108
-11,400 Reduced 75.0%
3,800 $35,000
Q4 2019

Feb 06, 2020

BUY
$7.99 - $37.6 $79,900 - $376,000
10,000 Added 192.31%
15,200 $121,000
Q3 2019

Oct 28, 2019

SELL
$19.17 - $27.4 $47,925 - $68,500
-2,500 Reduced 32.47%
5,200 $106,000
Q2 2019

Aug 09, 2019

BUY
$22.93 - $42.84 $176,561 - $329,868
7,700 New
7,700 $200,000
Q4 2018

Feb 05, 2019

SELL
$37.1 - $50.11 $18,550 - $25,055
-500 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$36.35 - $55.2 $18,175 - $27,600
500 New
500 $25,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.